Clinical Trials · NCT06247748
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Beijing Dongfang Biotech Co., Ltd.
- Enrollment
- 28
- Start date
- Oct 2023
- Locations
- 1 site, China
- Primary endpoint
- The Metformin Peak Concentration (Cmax )